Halozyme To Host Second Quarter 2017 Financial Results Conference Call

Go back to Halozyme To Host Second Quarter 2017 Financial Results Conference Call
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 112.89 -1.01 (0.89%)
Previous Close $113.90    52 Week High $18.39 
Open $113.34    52 Week Low $6.96 
Day High $113.94    P/E N/A 
Day Low $112.10    EPS $-0.58 
Volume 2,187,640